POINT Biopharma Global In... (PNT)
NASDAQ: PNT
· Real-Time Price · USD
12.50
0.02 (0.16%)
At close: Dec 26, 2023, 10:00 PM
POINT Biopharma Global Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 96.55M | 97.31M | 98.14M | 98.29M | -79.17M | -72.27M | -56.5M | -45.9M | -37.26M | -23.19M | -14.38M |
Depreciation & Amortization | 2.6M | 2.13M | 1.71M | 1.4M | 992.84K | 595.92K | 236.07K | 11.84K | n/a | 3.21M | 3.21M |
Stock-Based Compensation | 5.59M | 4.8M | 4.11M | 3.55M | 2.92M | 2.19M | 2.27M | 2.3M | 2.07M | 2.13M | 1.02M |
Other Working Capital | 13.2M | 16.3M | 62.73M | 76.03M | 9.44M | 9.56M | 4.9M | 846.16K | -2.06M | -4.34M | -2.05M |
Other Non-Cash Items | -8.39M | -8.96M | -5.18M | -2.02M | -512.67K | -133.81K | 161.41K | 164.21K | 178.89K | -3.04M | -3.21M |
Deferred Income Tax | -2.07K | 1.45M | 1.45M | 1.45M | 2.87K | -98.61K | -98.61K | -98.61K | -101.49K | -73.5K | -73.5K |
Change in Working Capital | 15.7M | 21.12M | 71.38M | 80.85M | 9.06M | 10.79M | 9.71M | -1.18M | -798.01K | 30.55K | -1.64M |
Operating Cash Flow | 112.06M | 117.86M | 171.62M | 183.52M | -66.71M | -58.94M | -44.22M | -44.7M | -35.9M | -20.93M | -15.06M |
Capital Expenditures | -19.32M | -20.54M | -15.35M | -12.77M | -11.39M | -6.03M | -9.56M | -8.8M | -11.81M | -15.65M | -9.98M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -205.41M | -243.69M | -276.45M | -126.94M | -39.28M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -5M | -5M | -126.56M | -126.56M | -126.56M | -126.56M | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -229.73M | -269.23M | -418.37M | -266.26M | -177.24M | -132.59M | -9.56M | -8.8M | -11.81M | -15.65M | -9.98M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 13.5M | 130.55M | 130.5M | 130.36M | 96.36M | -24.65M | 240.78M | 261.23M | 414.16M | 435.66M | 170.23M |
Financial Cash Flow | 13.5M | 130.55M | 130.5M | 130.36M | 116.9M | -4.1M | 261.32M | 281.77M | 418.87M | 440.37M | 174.94M |
Net Cash Flow | -104.18M | -20.81M | -116.25M | 47.61M | -127.04M | -195.63M | 207.54M | 228.27M | 234.06M | 266.69M | 12.8M |
Free Cash Flow | 92.74M | 97.32M | 156.27M | 170.75M | -78.1M | -64.96M | -53.78M | -53.5M | -47.71M | -36.58M | -25.05M |